[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100356799":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":47,"locations":54,"responsibleParty":70,"collaborators":52,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":52,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":52,"enrollmentInfo":82,"targetDuration":52,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":52,"overallStatus":56,"whyStopped":52,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"vildagliptin","EXPERIMENTAL","vildagliptin 50 mg twice daily",[13],"Drug: Vildagliptin",{"label":15,"type":16,"description":17,"interventionNames":18},"vildagliptin\\metformin","ACTIVE_COMPARATOR","vildagliptin\\\\metformin twice daily",[19],"Drug: vildagliptin\\metformin",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Vildagliptin","vildagliptin twice daily",[9],[27],"dibavally",{"type":22,"name":15,"description":17,"armGroupLabels":29,"otherNames":30},[15],[31],"dibavally plus",[33,37,40,43],{"name":34,"affiliation":35,"role":36},"Aya G Moussa, Msc","Tanta University - Faculty of Pharmacy","PRINCIPAL_INVESTIGATOR",{"name":38,"affiliation":39,"role":36},"Osama M Ibrahim, Prof","Prof of Clinical Pharmacy",{"name":41,"affiliation":39,"role":42},"Gamal Alazab, ass. Prof.","STUDY_DIRECTOR",{"name":44,"affiliation":45,"role":46},"Yasser Abdel Raouf, Ass Prof","Tanta University-Faculty of Medicine","STUDY_CHAIR",[48],{"name":49,"role":50,"phone":51,"phoneExt":52,"email":53},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440",null,"sheriefabdelsalam@yahoo.com",[55],{"facility":5,"status":56,"city":57,"state":52,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"RECRUITING","Tanta","35111","Egypt","EG",{"type":62,"coordinates":63},"Point",[64,65],31.00192,30.78847,{"lat":65,"lon":64},[68],{"name":69,"role":50,"phone":52,"phoneExt":52,"email":52},"Sherief Abd-Elsalam",{"type":71,"investigatorFullName":69,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":52,"oldOrganization":52},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100356799","phase-3-clinical-study-evaluating-vildagliptin-versus-vildagliptinmetformin-on-nafld-with-dm-100356799",false,"NCT03925701","Clinical Study Evaluating Vildagliptin Versus Vildagliptin\u002FMetformin on NAFLD With DM","Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin\u002FMetformin on NAFLD With DM","Inclusion Criteria:\n\n* NAFLD and type 2 DM\n\nExclusion Criteria:\n\n* Viral hepatitis.\n* Child score more than 6.\n* renal impairment.","ALL","18 Years",{"count":83,"type":84},120,"ESTIMATED","INTERVENTIONAL",[87],"PHASE3","Clinical study evaluating vildagliptin versus vildagliptin\u002Fmetformin on NAFLD with DM.",[90],"dm","2019-04-26",{"date":93,"type":94},"2019-04-29","ACTUAL",{"date":96,"type":94},"2019-04-01",{"date":98,"type":84},"2028-12",{"name":69,"class":6},1]